日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

A phase 3 study of intensive chemotherapy with or without dasatinib in core-binding factor acute myeloid leukemia

一项针对核心结合因子急性髓系白血病患者的强化化疗联合或不联合达沙替尼的3期研究

期刊:Blood
影响因子:23.1
doi:10.1182/blood.2025030722
Döhner, Hartmut; Späth, Daniela; Saadati, Maral; Fiedler, Walter; Götze, Katharina; Koller, Elisabeth; Westermann, Jörg; Vogel, Wichard; Heuser, Michael; Lübbert, Michael; Tischler, Hans-Joachim; Germing, Ulrich; Teichmann, Lino L; Fransecky, Lars; Wölfler, Albert; Nachbaur, David; Hertenstein, Bernd; Schroers, Roland; Martens, Uwe; von Harsdorf, Stephanie; Radsak, Markus; Aschauer, Gregor; Weißhaar, Stefanie; Corbacioglu, Andrea; Schrade, Anika; Gaidzik, Verena I; Thol, Felicitas; Paschka, Peter; Bullinger, Lars; Benner, Axel; Döhner, Konstanze; Ganser, Arnold
白血病
发表日期：2026
文献求助 收藏

Low-dose azacitidine, pioglitazone and all-trans retinoic acid is safe in patients aged ≥60 years with acute myeloid leukemia refractory to standard induction chemotherapy (AMLSG 26-16/AML-ViVA): results of the safety run-in phase

低剂量阿扎胞苷、吡格列酮和全反式维甲酸治疗对接受标准诱导化疗无效的≥60岁急性髓系白血病患者是安全的（AMLSG 26-16/AML-ViVA）：安全性导入期结果

期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2023.283864
Heudobler, Daniel; Luke, Florian; Hahn, Joachim; Grube, Matthias; Schlosser, Pavla; Kremers, Stephan; Sudhoff, Thomas; Westermann, Jorg; Hutter-Kronke, Marie Luise; Schlenk, Richard F; Weber, Daniela; Paschka, Peter; Zeman, Florian; Dohner, Hartmut; Herr, Wolfgang; Reichle, Albrecht; Thomas, Simone
白血病
发表日期：2024
文献求助 收藏

The Urine Light Chain/eGFR Quotient as a Tool to Rule out Cast Nephropathy in Myeloma-Associated Kidney Failure

尿轻链/eGFR 比值作为排除多发性骨髓瘤相关肾衰竭中管型肾病的一种工具

期刊:Biomedicines
影响因子:3.9
doi:10.3390/biomedicines12051032
Klank, David; Löffler, Christian; Friedrich, Julian; Hoffmann, Martin; Paschka, Peter; Bergner, Raoul
多发性骨髓瘤
骨髓瘤
发表日期：2024
文献求助 收藏

Palbociclib in Acute Leukemias With KMT2A-rearrangement: Results of AMLSG 23-14 Trial

帕博西尼治疗伴有KMT2A重排的急性白血病：AMLSG 23-14试验结果

期刊:Hemasphere
影响因子:14.6
doi:10.1097/HS9.0000000000000877
Gaidzik, Verena I; Paschka, Peter; Schlenk, Richard F; Weber, Daniela; Fröhling, Stefan; Krämer, Alwin; Wäsch, Ralph; Westermann, Jörg; Mayer, Karin; de Wit, Maike; Fiedler, Walter; Benner, Axel; Heuser, Michael; Thol, Felicitas; Döhner, Konstanze; Ganser, Arnold; Döhner, Hartmut
白血病
KMT2A
发表日期：2023
文献求助 收藏

Midostaurin plus intensive chemotherapy for younger and older patients with AML and FLT3 internal tandem duplications

米哚妥林联合强化化疗适用于患有急性髓系白血病和FLT3内部串联重复的年轻及老年患者

期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2022007223
Döhner, Hartmut; Weber, Daniela; Krzykalla, Julia; Fiedler, Walter; Wulf, Gerald; Salih, Helmut; Lübbert, Michael; Kühn, Michael W M; Schroeder, Thomas; Salwender, Hans; Götze, Katharina; Westermann, Jörg; Fransecky, Lars; Mayer, Karin; Hertenstein, Bernd; Ringhoffer, Mark; Tischler, Hans-Joachim; Machherndl-Spandl, Sigrid; Schrade, Anika; Paschka, Peter; Gaidzik, Verena I; Theis, Frauke; Thol, Felicitas; Heuser, Michael; Schlenk, Richard F; Bullinger, Lars; Saadati, Maral; Benner, Axel; Larson, Richard; Stone, Richard; Döhner, Konstanze; Ganser, Arnold
白血病
FLT3
发表日期：2022
文献求助 收藏

Single Center Experience Using Monoclonal COVID-19 Antibodies in the Management of Immunocompromised Patients with COVID-19

单中心应用单克隆COVID-19抗体治疗免疫功能低下COVID-19患者的经验

期刊:Microorganisms
影响因子:4.2
doi:10.3390/microorganisms10122490
Klank, David; Claus, Bernd; Bergner, Raoul; Paschka, Peter
免疫/内分泌
发表日期：2022
文献求助 收藏

Clonal evolution of acute myeloid leukemia with FLT3-ITD mutation under treatment with midostaurin

米哚妥林治疗下伴有FLT3-ITD突变的急性髓系白血病的克隆演变

期刊:Blood
影响因子:23.1
doi:10.1182/blood.2020007626
Schmalbrock, Laura K; Dolnik, Anna; Cocciardi, Sibylle; Sträng, Eric; Theis, Frauke; Jahn, Nikolaus; Panina, Ekaterina; Blätte, Tamara J; Herzig, Julia; Skambraks, Sabrina; Rücker, Frank G; Gaidzik, Verena I; Paschka, Peter; Fiedler, Walter; Salih, Helmut R; Wulf, Gerald; Schroeder, Thomas; Lübbert, Michael; Schlenk, Richard F; Thol, Felicitas; Heuser, Michael; Larson, Richard A; Ganser, Arnold; Stunnenberg, Hendrik G; Minucci, Saverio; Stone, Richard M; Bloomfield, Clara D; Döhner, Hartmut; Döhner, Konstanze; Bullinger, Lars
白血病
FLT3
发表日期：2021
文献求助 收藏

Monoclonal Antibodies for the Prevention and Treatment of COVID-19 Disease in Patients With Hematological Malignancies: Two Case Reports and a Literature Review

单克隆抗体在血液系统恶性肿瘤患者中预防和治疗 COVID-19 的疗效：两例病例报告及文献综述

期刊:Hemasphere
影响因子:14.6
doi:10.1097/HS9.0000000000000651
Klank, David; Hoffmann, Martin; Claus, Bernd; Zinke, Florian; Bergner, Raoul; Paschka, Peter
单克隆抗体
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏

Cluster of differentiation 33 single nucleotide polymorphism rs12459419 is a predictive factor in patients with nucleophosmin1-mutated acute myeloid leukemia receiving gemtuzumab ozogamicin

分化簇33单核苷酸多态性rs12459419是接受吉妥珠单抗治疗的核磷蛋白1突变型急性髓系白血病患者的预测因子。

期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2021.278894
Teich, Katrin; Krzykalla, Julia; Kapp-Schwoerer, Silke; Gaidzik, Verena I; Schlenk, Richard F; Paschka, Peter; Weber, Daniela; Fiedler, Walter; Kühn, Michael W M; Schroeder, Thomas; Mayer, Karin; Lübbert, Michael; Ramachandran, Dhanya; Benner, Axel; Ganser, Arnold; Döhner, Hartmut; Heuser, Michael; Döhner, Konstanze; Thol, Felicitas
白血病
发表日期：2021
文献求助 收藏

Posttransplantation MRD monitoring in patients with AML by next-generation sequencing using DTA and non-DTA mutations

利用DTA和非DTA突变进行二代测序，对AML患者进行移植后微小残留病监测

期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2021004367
Heuser, Michael; Heida, Bennet; Büttner, Konstantin; Wienecke, Clara Philine; Teich, Katrin; Funke, Carolin; Brandes, Maximilian; Klement, Piroska; Liebich, Alessandro; Wichmann, Martin; Neziri, Blerina; Chaturvedi, Anuhar; Kloos, Arnold; Mintzas, Konstantinos; Gaidzik, Verena I; Paschka, Peter; Bullinger, Lars; Fiedler, Walter; Heim, Albert; Puppe, Wolfram; Krauter, Jürgen; Döhner, Konstanze; Döhner, Hartmut; Ganser, Arnold; Stadler, Michael; Hambach, Lothar; Gabdoulline, Razif; Thol, Felicitas
发表日期：2021
文献求助 收藏